Codes / ICD10CM / M1A.1311

M1A.1311 Lead-induced chronic gout, right wrist, with tophus (tophi)

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Lead-Induced Chronic Gout, Right Wrist, With Tophus (Tophi)

Summary

Lead-induced chronic gout is a form of arthritis caused by prolonged lead exposure, leading to elevated uric acid levels and recurrent joint inflammation. This specific presentation affects the right wrist and includes the presence of tophi (urate crystal deposits), resulting in persistent symptoms and potential tissue damage if untreated.

Causes

This condition results from chronic lead exposure, which disrupts uric acid metabolism and causes crystal accumulation in joints. Lead interferes with renal excretion of uric acid, leading to hyperuricemia and subsequent joint inflammation. Over time, urate crystals deposit in tissues, forming tophi. Exposure sources include occupational contact, contaminated environments, or historical lead-based products.

Risk Factors

  • Long-term occupational or environmental lead exposure
  • History of gout or hyperuricemia
  • Male gender
  • Middle-aged or older adults

Symptoms

  • Recurrent episodes of intense joint pain in the right wrist
  • Persistent swelling, redness, and warmth in the affected area
  • Stiffness and limited wrist mobility
  • Presence of tophi (hard, painless lumps) under the skin near the right wrist
  • Flare-ups triggered by stress, diet, or illness

Diagnosis

Diagnosis involves clinical evaluation, laboratory tests, and imaging. Blood tests measure uric acid levels, while joint fluid analysis detects urate crystals. Imaging (e.g., X-rays or ultrasounds) assesses joint damage, confirms the right wrist as the affected site, and identifies tophi.

Treatment Options

  • Medications to reduce uric acid levels (e.g., allopurinol)
  • Anti-inflammatory drugs for pain and swelling
  • Local treatments for tophi, such as aspiration or surgery (if severe)
  • Chelation therapy to reduce lead levels (if ongoing exposure)
  • Lifestyle modifications to avoid lead sources and manage flare-ups

Prognosis and Follow-Up

With proper treatment, symptoms can be managed, and joint damage may be slowed. Tophi may shrink or stabilize but often persist. Regular monitoring of uric acid levels and joint health is essential to prevent progression. Follow-up care focuses on maintaining lead exposure avoidance and adjusting therapy as needed.

Complications

  • Chronic joint damage or deformity in the right wrist
  • Persistent tophi that may ulcerate or become infected
  • Kidney stones or renal impairment from prolonged hyperuricemia
  • Increased risk of acute gout flares

Lifestyle & Prevention

  • Avoid occupational or environmental lead exposure
  • Maintain a low-purine diet to reduce uric acid production
  • Stay hydrated to support kidney function
  • Monitor and manage comorbidities like hypertension or diabetes
  • Use protective equipment in high-risk work environments

When to Seek Professional Help

Seek care if you experience sudden, severe wrist pain, swelling, or redness, or if tophi become painful, infected, or limit mobility. Prompt evaluation is important to prevent joint damage and address lead exposure risks.

Tips for Medical Coders

Document the specific site (right wrist) and the presence of tophi to accurately assign M1A.1311. Ensure clinical notes specify lead exposure history, tophi location, and joint involvement. Use this code only when the condition is chronic and lead-induced, with tophi confirmed.

Book a walkthrough

M1A.1311 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.